Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

11.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.5K
Synteny and Evolution02:31

Synteny and Evolution

3.2K
John H. Renwick first coined the term “synteny” in 1971, which refers to the genes present on the same chromosomes, even if they are not genetically linked. The species with common ancestry tend to show conserved syntenic regions. Therefore, the concept of synteny is nowadays used to describe the evolutionary relationship between species.
Around 80 million years ago, the human and mice lineages diverged from the common ancestor. During the course of evolution, the ancestral...
3.2K
Cancer02:18

Cancer

47.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.7K
Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
What is Evolutionary History?02:35

What is Evolutionary History?

36.2K
Scientists record evolutionary history by analyzing fossil, morphological, and genetic data. The fossil record documents the history of life on Earth and provides evidence for evolution. However, both fossil and living organisms offer evidence that outlines Earth’s evolutionary history.
36.2K
The Evidence for Evolution02:55

The Evidence for Evolution

42.3K
Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
42.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PD-L1 CPS in gastroesophageal cancer: differences in routine care versus Checkmate 649 and implications for biopsy-site choice and assay standardisation.

British journal of cancer·2026
Same author

Clinical and experimental treatment of advanced melanoma with a focus on immunotherapy.

Clinical and experimental immunology·2025
Same author

Phenotypic heterogeneity and plasticity in colorectal cancer metastasis.

Cell genomics·2025
Same author

UK cancer vaccine advance - Recognising and realising opportunities.

Cambridge prisms. Precision medicine·2025
Same author

Resistance Management for Cancer: Lessons from Farmers.

Cancer research·2024
Same author

Systemic therapies and primary tumour downsizing in renal cell carcinoma: a real-world comparison of anti-angiogenic and immune checkpoint inhibition regimens.

World journal of urology·2024

Related Experiment Video

Updated: May 30, 2025

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.3K

Cancer evolution: from Darwin to the Extended Evolutionary Synthesis.

Thomas Savy1, Lucy Flanders2, Thaneswari Karpanasamy1

  • 1Barts Cancer Institute, Queen Mary University of London, London, UK.

Trends in Cancer
|January 29, 2025
PubMed
Summary

Cancer evolution from premalignant to drug-resistant stages is driven by Darwinian principles. Integrating cell plasticity with the Extended Evolutionary Synthesis (EES) offers a new clinical framework.

Keywords:
biomarkerscancer evolutioncellular plasticitydrug resistancemacroevolutionmetastasismutagenesis

More Related Videos

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:49

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

99
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

4.8K

Related Experiment Videos

Last Updated: May 30, 2025

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.3K
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:49

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

99
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

4.8K

Area of Science:

  • Evolutionary biology
  • Cancer biology
  • Genomics

Background:

  • Cancer's evolutionary nature is well-established.
  • Advanced sequencing and preclinical models illuminate cancer progression.
  • Understanding cancer evolution is crucial for clinical applications.

Purpose of the Study:

  • To summarize recent advances in cancer evolution research.
  • To distill evolutionary principles relevant to clinical oncology.
  • To propose an integrated conceptual framework for cancer evolution.

Main Methods:

  • Review of recent genetic and single-cell sequencing studies.
  • Analysis of preclinical cancer models.
  • Distillation of evolutionary principles and their clinical relevance.

Main Results:

  • Cancer cell and microenvironmental plasticity are key to Darwinian evolution.
  • These processes are intertwined and impact disease progression.
  • Existing frameworks may not fully capture cancer's complexity.

Conclusions:

  • The Extended Evolutionary Synthesis (EES) provides a necessary conceptual framework.
  • Integrating EES with cancer biology can advance clinical strategies.
  • A unified understanding of cancer evolution is essential for therapeutic development.